Hypo-phosphorylation of the Retinoblastoma Protein (pRb) by Cyclin D:Cdk4/6 Complexes Results in Active PRb

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1997 Oct 6

PMID 9380698

Citations 88

Authors

S A Ezhevsky

H Nagahara

D R Gius

M C Wei

S F Dowdy

Affiliations

Soon will be listed here.

Abstract

In cycling cells, the retinoblastoma protein (pRb) is un- and/or hypo-phosphorylated in early G1 and becomes hyper-phosphorylated in late G1. The role of hypo-phosphorylation and identity of the relevant kinase(s) remains unknown. We show here that hypo-phosphorylated pRb associates with E2F in vivo and is therefore active. Increasing the intracellular concentration of the Cdk4/6 specific inhibitor p15(INK4b) by transforming growth factor beta treatment of keratinocytes results in G1 arrest and loss of hypo-phosphorylated pRb with an increase in unphosphorylated pRb. Conversely, p15(INK4b)-independent transforming growth factor beta-mediated G1 arrest of hepatocellular carcinoma cells results in loss of Cdk2 kinase activity with continued Cdk6 kinase activity and pRb remains only hypo-phosphorylated. Introduction of the Cdk4/6 inhibitor p16(INK4a) protein into cells by fusion to a protein transduction domain also prevents pRb hypo-phosphorylation with an increase in unphosphorylated pRb. We conclude that cyclin D:Cdk4/6 complexes hypo-phosphorylate pRb in early G1 allowing continued E2F binding.

Citing Articles

Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells.

Pham T, Ahmed M, Lai T, Bahar M, Hwang J, Maulidi R Int J Mol Sci. 2024; 25(5).

PMID: 38474202 PMC: 10932151. DOI: 10.3390/ijms25052956.

TAT peptide at treatment-level concentrations crossed brain endothelial cell monolayer independent of receptor-mediated endocytosis or peptide-inflicted barrier disruption.

Wu M, Wang E, Lai T PLoS One. 2023; 18(10):e0292681.

PMID: 37819924 PMC: 10566733. DOI: 10.1371/journal.pone.0292681.

Cyclin-dependent kinases: Masters of the eukaryotic universe.

Pluta A, Studniarek C, Murphy S, Norbury C Wiley Interdiscip Rev RNA. 2023; :e1816.

PMID: 37718413 PMC: 10909489. DOI: 10.1002/wrna.1816.

Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?.

Dowdy S RNA. 2023; 29(4):396-401.

PMID: 36669888 PMC: 10019367. DOI: 10.1261/rna.079507.122.

Targeting chromosome 12q amplification in relapsed glioblastoma: the use of computational biological modeling to identify effective therapy-a case report.

Castro M, Khanlou N, Fallah A, Pampana A, Alam A, Lala D Ann Transl Med. 2023; 10(23):1289.

PMID: 36618786 PMC: 9816820. DOI: 10.21037/atm-2022-62.

References

Green M, Loewenstein P . Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell. 1988; 55(6):1179-88. DOI: 10.1016/0092-8674(88)90262-0. View

Lee W, Shew J, Hong F, SERY T, Donoso L, Young L . The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature. 1987; 329(6140):642-5. DOI: 10.1038/329642a0. View

DeCaprio J, Ludlow J, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H . The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 1989; 58(6):1085-95. DOI: 10.1016/0092-8674(89)90507-2. View

Mittnacht S, Weinberg R . G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell. 1991; 65(3):381-93. DOI: 10.1016/0092-8674(91)90456-9. View

Chellappan S, Hiebert S, Mudryj M, Horowitz J, Nevins J . The E2F transcription factor is a cellular target for the RB protein. Cell. 1991; 65(6):1053-61. DOI: 10.1016/0092-8674(91)90557-f. View

Bagchi S, Weinmann R, Raychaudhuri P . The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F. Cell. 1991; 65(6):1063-72. DOI: 10.1016/0092-8674(91)90558-g. View

Weintraub S, Prater C, Dean D . Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 1992; 358(6383):259-61. DOI: 10.1038/358259a0. View

Helin K, Lees J, Vidal M, Dyson N, Harlow E, Fattaey A . A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell. 1992; 70(2):337-50. DOI: 10.1016/0092-8674(92)90107-n. View

Kaelin Jr W, Krek W, Sellers W, DeCaprio J, Ajchenbaum F, Fuchs C . Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell. 1992; 70(2):351-64. DOI: 10.1016/0092-8674(92)90108-o. View

10.

Won K, Xiong Y, Beach D, Gilman M . Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci U S A. 1992; 89(20):9910-4. PMC: 50243. DOI: 10.1073/pnas.89.20.9910. View

11.

Lees E, Harlow E . Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase. Mol Cell Biol. 1993; 13(2):1194-201. PMC: 359004. DOI: 10.1128/mcb.13.2.1194-1201.1993. View

12.

Ajchenbaum F, Ando K, DeCaprio J, Griffin J . Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J Biol Chem. 1993; 268(6):4113-9. View

13.

Dowdy S, Hinds P, Louie K, Reed S, Arnold A, Weinberg R . Physical interaction of the retinoblastoma protein with human D cyclins. Cell. 1993; 73(3):499-511. DOI: 10.1016/0092-8674(93)90137-f. View

14.

Fawell S, Seery J, Daikh Y, Moore C, Chen L, Pepinsky B . Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A. 1994; 91(2):664-8. PMC: 43009. DOI: 10.1073/pnas.91.2.664. View

15.

Mittnacht S, Lees J, Desai D, Harlow E, MORGAN D, Weinberg R . Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J. 1994; 13(1):118-27. PMC: 394785. DOI: 10.1002/j.1460-2075.1994.tb06241.x. View

16.

Matsushime H, Quelle D, Shurtleff S, Shibuya M, Sherr C, Kato J . D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol. 1994; 14(3):2066-76. PMC: 358567. DOI: 10.1128/mcb.14.3.2066-2076.1994. View

17.

Meyerson M, Harlow E . Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol. 1994; 14(3):2077-86. PMC: 358568. DOI: 10.1128/mcb.14.3.2077-2086.1994. View

18.

La Thangue N . DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control. Trends Biochem Sci. 1994; 19(3):108-14. DOI: 10.1016/0968-0004(94)90202-x. View

19.

Hannon G, Beach D . p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994; 371(6494):257-61. DOI: 10.1038/371257a0. View

20.

Dunaief J, Strober B, Guha S, Khavari P, ALIN K, LUBAN J . The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell. 1994; 79(1):119-30. DOI: 10.1016/0092-8674(94)90405-7. View